This document provides a short summary of this study for a general audience. You can
find more information in the scientific summary of the study. A link to the summary is
provided at the end of this document.
Study names
Short Title: A study to compare treatment guided by the Asthma Control Test with
usual treatment in Chinese patients.
Full Scientific Title: The effectiveness of Asthma Control Test guided treatment
compared with usual care in China adult asthma patients.
Study Number: 201097
Who sponsored this study?
GlaxoSmithKline (GSK)
GSK Clinical Support Help Desk
Website: clinicalsupporthd.gsk.com/contact.html
Email: GSKClinicalSupportHD@gsk.com
General information about the clinical study
When and where was this study done?
The study started in August 2016 and ended in August 2019. All study sites were in
China.
What was the main objective of this study?
Asthma is a long-term condition of the airways. When the airways are inflamed, they
become narrow. This narrowing can cause coughing, wheezing, chest tightness, and
shortness of breath.
Simple methods have been developed to help doctors assess asthma control in
patients. One of these methods is the Asthma Control Test (ACT), which is a short
survey. The ACT was designed to measure how well a patientâ€™s asthma has been
Use of the data and information contained in this Document is unrestricted, provided that it may not
be used in applications by others for regulatory approval of a product. While not required, when using
these data, we ask that proper credit or attribution of GSK as the source of the data be given. GSK
disclaims liability for all uses of the data by users of this Document, to the fullest extent permitted by
applicable law. No trademark, patent, or regulatory/data exclusivity rights held by GSK are waived,
licensed or otherwise affected.